In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Healthequity Inc (NASDAQ: HQY) closed at $101.28 down -1.56% from its previous closing price of $102.89. In other words, the price has decreased by -$1.56 from its previous closing price. On the day, 1.32 million shares were traded. HQY stock price reached its highest trading level at $102.75 during the session, while it also had its lowest trading level at $100.1.
Ratios:
For a deeper understanding of Healthequity Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 30.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.93. For the most recent quarter (mrq), Quick Ratio is recorded 4.06 and its Current Ratio is at 4.06. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.52.
On March 25, 2025, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also lowered its target price recommendation from $120 to $115.
On December 04, 2024, Mizuho started tracking the stock assigning a Outperform rating and target price of $126.Mizuho initiated its Outperform rating on December 04, 2024, with a $126 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 06 ’25 when Kessler Jon sold 134,183 shares for $112.08 per share. The transaction valued at 15,038,655 led to the insider holds 253,510 shares of the business.
Kessler Jon sold 97,767 shares of HQY for $10,954,322 on Jun 06 ’25. The Former Director now owns 75,000 shares after completing the transaction at $112.05 per share. On Jun 06 ’25, another insider, Rosner Elimelech, who serves as the EVP, CHIEF TECHNOLOGY OFFICER of the company, sold 58,000 shares for $112.56 each. As a result, the insider received 6,528,434 and left with 75,689 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HQY now has a Market Capitalization of 8758227968 and an Enterprise Value of 9878022144. As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 73.72, and their Forward P/E ratio for the next fiscal year is 23.03. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.05 while its Price-to-Book (P/B) ratio in mrq is 4.14. Its current Enterprise Value per Revenue stands at 7.947 whereas that against EBITDA is 24.348.
Stock Price History:
The Beta on a monthly basis for HQY is 0.55, which has changed by 0.22659564 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, HQY has reached a high of $116.65, while it has fallen to a 52-week low of $65.01. The 50-Day Moving Average of the stock is 2.76%, while the 200-Day Moving Average is calculated to be 5.80%.
Shares Statistics:
For the past three months, HQY has traded an average of 1.10M shares per day and 1002640 over the past ten days. A total of 86.71M shares are outstanding, with a floating share count of 84.54M. Insiders hold about 2.24% of the company’s shares, while institutions hold 107.90% stake in the company. Shares short for HQY as of 1749772800 were 5262496 with a Short Ratio of 4.78, compared to 1747267200 on 5817919. Therefore, it implies a Short% of Shares Outstanding of 5262496 and a Short% of Float of 7.049999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
